BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros - Wikidata - wikimedia - TriplyDB

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

http://www.wikidata.org/entity/Q57734316

about

Cell cycle-specific function of Ikaros in human leukemia Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia Acute lymphoblastic leukaemia Selective regulation of lymphopoiesis and leukemogenesis by individual zinc fingers of Ikaros An allele of IKZF1 (Ikaros) conferring susceptibility to childhood acute lymphoblastic leukemia protects against type 1 diabetes dbCRID: a database of chromosomal rearrangements in human diseases Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia Role of Ikaros in T-cell acute lymphoblastic leukemia DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome Immunologically silent cancer clone transmission from mother to offspring The Philadelphia chromosome in leukemogenesis New Developments in Chronic Myeloid Leukemia: Implications for Therapy Mouse models for radiation-induced cancers New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia Genetic abnormalities associated with acute lymphoblastic leukemia Emerging technologies in paediatric leukaemia ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies Long-Range Regulation of V(D)J Recombination Novel agents and biomarkers for acute lymphoid leukemia Genomic profiling of B-progenitor acute lymphoblastic leukemia MicroRNAs in B cell development and malignancy Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine A health-care system perspective on implementing genomic medicine: pediatric acute lymphoblastic leukemia as a paradigm Mouse models for efficacy testing of agents against radiation carcinogenesis—a literature review Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1 IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.The Ikaros family of zinc-finger proteins Zebrafish Models of Human Leukemia: Technological Advances and Mechanistic Insights Childhood acute lymphoblastic leukemia: Integrating genomics into therapy Prognostification of ALL by Cytogenetics Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the Ikaros gene Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia Co-existence of IL7R high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunction Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age?Toward an evolutionary model of cancer: Considering the mechanisms that govern the fate of somatic mutations Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia A target-disease network model of second-generation BCR-ABL inhibitor action in Ph+ ALL Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia

P2860

Q24298114-9E9B76C8-986C-4958-90D0-F3E8FF1E1629 Q24597256-81F2E1ED-9729-4886-9166-C8F9E14B93D5 Q24602387-0641FFBF-F380-4DF1-BE2B-0BEF7DCD26F1 Q24607867-544F803A-43C4-4773-A662-2B4B72BD2C31 Q24612348-A477B958-B33B-42AB-9B7D-8AA19DF5DDFE Q24615840-A2E631C6-5FA9-4002-B642-FA1AA40616E8 Q24622397-BEE057F2-147D-41EA-9635-8580FE24817A Q24633359-CD5CB650-C3AD-4FF2-86F5-8B21AE734CBF Q24644436-78F3EABE-3FBF-4C87-8D5E-57056890AAB6 Q24650876-1B5E0392-909D-40AB-995C-C5EA4D07D394 Q26745531-11636014-4CDE-4D54-93D3-D19447319A96 Q26745669-9CD3AFFA-1A1A-476C-BEDF-52C04EA4A2AF Q26747129-F8724644-6D0B-40A7-9148-72E242F7854C Q26749177-7D30346F-4235-46C9-8F58-C46D70CC85B3 Q26753823-09C669E1-A45B-4172-8976-F88489678BE9 Q26770327-9B7C7361-6CB9-409C-BF71-E1B10DAC568C Q26770729-5FFADC1E-31BC-4891-BFB4-FAEFC76793F1 Q26782103-356BED22-CC20-497C-8D67-6541B259FD0F Q26829775-D30B0B4C-D9F3-4A2F-B98D-6199E3B29115 Q26829976-2F11671B-65F2-4B7A-8EAA-B96FA6FB1D34 Q26862811-772B4C10-93B1-4B8C-94AD-2FEB05024958 Q26864460-FD071EAF-51E7-4A4C-8FC0-DD797CD7F6BD Q26866379-52CF1D3B-4968-4F1E-A1AE-4A40ECD0661A Q26999068-ADEF03BF-3356-48FB-953A-7C2025136B49 Q27025242-CD561F17-F969-43F6-BC25-1C368E1EA610 Q27687464-22111062-A704-4A36-A188-D1857EC34052 Q27851563-6AC24423-886D-4FB2-ABF1-2ECC0B2CC6D7 Q27851831-5B7C941F-4A0A-415E-9BFE-1B7A2DE3515C Q28066194-ED0BA3AE-7A63-4711-BA43-9FE4539E36CF Q28078210-33FC9EAF-C196-46D3-8C69-568CFB27B674 Q28080463-11F3F9EF-E442-4146-9009-FBFB720B5456 Q28087446-08AD6CA9-97AF-4824-848C-3EA5B46787F9 Q28114848-CE98F164-41FF-4870-899E-9488C8BF3216 Q28255265-A1BB1DF8-4438-4774-AAA8-59A818EF2ABC Q28276513-867ACE8D-4EC9-4EEE-AF95-B9111D6F7A7F Q28383732-C1C1B5EF-16E3-4FFB-AA74-4E490D2B3EF0 Q28384546-D6DBACB6-23F3-452A-A84B-47C0AE7207FB Q28390558-C0F9FE49-6C9B-4D20-BD4D-B581DEDEDF04 Q28534337-3A9CB599-F8E1-42A5-AD9B-8D9A4D7A9E1A Q28546078-738F7E5F-8385-4EF8-9DC9-BBE0B973AD23

P2860

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

http://www.wikidata.org/entity/Q57734316

description

article publié dans la revue scientifique Nature

@fr

scientific article published in Nature

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в Nature у квітні 2008

@uk

name

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

@en

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

@nl

type

label

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

@en

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

@nl

prefLabel

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

@en

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

@nl

P1433

Q57734316-C991BC03-A5FD-4262-BE01-3800C9DC4AA7

P1476

Q57734316-759EEB68-5854-4CB7-952D-1DA7561AD2C2

P2093

Q57734316-0387C7F8-8AA9-4AAD-8F89-8927E85FC1BE

Q57734316-3B0825CB-45EF-450A-A9D6-D87AE2C91D33

Q57734316-4CCBD081-3C22-4F58-9CDF-678A1A42CFD0

Q57734316-9CF8B1C0-7F3F-48CA-8B8E-F3248194258E

Q57734316-9F419D06-A08E-4B9A-BBB9-5C83F8F98257

Q57734316-AE79CFEF-40D8-42C2-9B4D-62C80B74ED6D

Q57734316-D51A655D-4AF2-4985-9805-6FE283A4270F

Q57734316-E20DD814-037F-4D2C-9531-3B9F5DF5176B

Q57734316-E691F09E-3A17-4067-AD58-29D21647EB1D

Q57734316-F32BD19E-46DC-4475-B47D-FF40B0C4BA6D

P2860

Q57734316-5569A94B-18B5-4558-8240-BD835A189BEA

Q57734316-D7179C04-2A9A-4EEE-B268-EC86B51E22F2

P2888

Q57734316-65BA6C15-937F-4055-AA03-533E0B1C2FA6

P304

Q57734316-5A4808CD-79F9-4076-8DB1-D2CD6B50B9D5

P31

Q57734316-02E23A17-D8CE-49D4-A6E5-48F117B5C54D

P356

Q57734316-7DB9E292-C44F-4A4F-A489-7E793A5A28E2

P407

Q57734316-4F3977D1-3293-4E4B-A0F5-E380A1BFDDC8

P433

Q57734316-D1735F34-AE73-454C-B94F-25BB5F7A42C1

P478

Q57734316-1B78B912-596B-41DE-9FAE-07E5BB6FFED1

P50

Q57734316-32E2BA8A-1C96-4A31-B18E-3B7CC2F1669C

Q57734316-8FDE5AE1-B26A-4461-AAA2-00963574C5F5

P577

Q57734316-E6F04054-3DDD-49F1-A8ED-9A3F19C121A6

P6179

Q57734316-8415B8CC-77E8-4540-BD23-A847B248FCCB

P698

Q57734316-39F5A143-AC11-4702-A164-0E73F76CDF45

P921

Q57734316-80F8F995-2954-46DC-9104-7E1EA0992954

P356

P1433

P1476

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

@en

P2093

Charles G. Mullighan

http://www.w3.org/2001/XMLSchema#string

Christopher B. Miller

http://www.w3.org/2001/XMLSchema#string

Ina Radtke

http://www.w3.org/2001/XMLSchema#string

James Dalton

http://www.w3.org/2001/XMLSchema#string

James R. Downing

http://www.w3.org/2001/XMLSchema#string

Jing Ma

http://www.w3.org/2001/XMLSchema#string

Letha A. Phillips

http://www.w3.org/2001/XMLSchema#string

Mary V. Relling

http://www.w3.org/2001/XMLSchema#string

Michelle M. Le Beau

http://www.w3.org/2001/XMLSchema#string

Sheila A. Shurtleff

http://www.w3.org/2001/XMLSchema#string

P2860

The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene

The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins

P2888

P304

110-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE06866

http://www.w3.org/2001/XMLSchema#string

P407

P433

7191

http://www.w3.org/2001/XMLSchema#string

P478

453

http://www.w3.org/2001/XMLSchema#string

P50

Deborah L. White

P577

2008-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1052983633

http://www.w3.org/2001/XMLSchema#string

P698

18408710

http://www.w3.org/2001/XMLSchema#string

P921